Vleggaar D et al. Dermatological implications of skeletal ageing: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol 2008;7:209-220.
Coleman SR et al. The anatomy of the ageing face: volume loss and changes in 3-dimensional topography. Aesthet Surg J 2006;26(suppl 1):S4- S9.
Zimbler MS et al. Anatomy and pathophysiology of facial ageing. Facial Plast Surg Clin North Am 2001;9:179-187.
Murphy MR et al. The ageing face consultation. W: Master Techniques in Facial Rejuvenation. Elsevier 2006;1-16.
Le Louarn C. Botulinum toxin and the Face Recurve® concept: decreasing resting tone and muscular regeneration. Ann Chir Plast Esth 2007;52:165-176.
Donofrio LM. Fat distribution: a morphologic study of the ageing face. Dermatol Surg 2000;26:1107-1111.
Valenga Baroni et al., Influence of aging on the quality of the skin of white women – the role of collagen. Acta cirurgica Brasileira 2012; 27: 736- 740
CE mark – Technical dossier (Whitepaper W113.05).
Nicolau PJ et al. Neocollagenesis after injection of a polycaprolactone-based dermal filler in a rabbit. Eur J Aesth Med Dermatol 2013;3(1):19- 26.
Moers-Carpi MM et al. Polycaprolactone for the Correction of Nasolabial Folds: A 24-Month, Prospective, Randomized, Controlled Clinical Trial. Dermatol Surg 2013;39:457-463.
Pitt CG. Aliphatic polyesters II The degradation of Poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivo. Biomaterials 1981;2:215-220.
Varani J. Decrease collagen production in chronologically aged skin. Am J Pathol 2006;168: 1861-1868.
Woodruff MA et al. The return of a forgotten polymer: polycaprolactone in the 21st century. Prog Polym Sci 2010;35(10):1217-1256.
Kim et al. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler.Journal of Cosmetic and Laser Therapy, 2014; Early Online: 1-3.
Galadari et al. A randomized, prospective, blinded, split face, single center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds. The Journal of Cosmetic Dermatology.
Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg 2004; 23(4):214-217.
Morhenn VB et al. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg 2002;28(6):484-490.
Anderson JM. Mechanism of inflammation and infection with implanted devices. Cardiovasc Pathol 1993;2:33S-41S.
Matlage BF et al. Tissue response to implanted polymers:The significance of sample shape. J Biomed Meter Res 1976;10:391-397.
Nicolau PJ. Long-Lasting and permanent fillers: Biomaterials influence over host response. Plast Reconstr Surg 2007; 119:2271-2286.